Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Report: Medtech tax has cost 33,000 jobs already
Mass Device
Wednesday, February 19, 2014 - 10:20am
tags:
devices, medical device tax, layoffs
Rise of Alnylam, ISIS Gives RNA Therapeutics Value
Wall St Cheat Sheet
Wednesday, February 19, 2014 - 10:17am
tags:
Alnylam, Isis Pharmaceuticals, RNAi
Glaxo Memo Shows Drug Industry Lobbying on E-Cigarettes
Bloomberg
Wednesday, February 19, 2014 - 9:55am
tags:
GSK, smoking cessation, e-cigarettes
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Yahoo/Zacks.com
Wednesday, February 19, 2014 - 9:26am
tags:
Regeneron, Eylea, Gilead Sciences, ledipasvir, Sovaldi, hepatitis C, Cangrelor, The Medicines Company
Should FDA and EMA Team up to Approve Drugs on a Reciprocal Basis?
Regulatory Focus
Wednesday, February 19, 2014 - 8:57am
tags:
FDA, drug approvals, Europe, EMA
Tokyo prosecutors raid Novartis Japan offices in probe
Reuters
Wednesday, February 19, 2014 - 8:46am
tags:
Japan, Diovan, Novartis
The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind
Motley Fool
Wednesday, February 19, 2014 - 8:44am
tags:
Myriad Genetics, Questcor, Ziopharm, Sarepta Therapeutics, MannKind
Can a New Indication for Lyrica Help Results at Pfizer?
Motley Fool
Wednesday, February 19, 2014 - 8:42am
tags:
Lyrica, Pfizer, restless legs syndrome
Eli Lilly's Ramucirumab for lung cancer meets Phase III survival endpoint
Yahoo/Fly on the Wall
Wednesday, February 19, 2014 - 8:41am
tags:
Eli Lilly, ramucirumab, non-small cell lung cancer
Teva decides not to proceed to randomization stage of trial for laquinimod
Yahoo/Fly on the Wall
Wednesday, February 19, 2014 - 8:40am
tags:
laquinimod, clinical trials, Teva Pharmaceuticals, Relapsing Remitting Multiple Sclerosis, RRMS, MS, Active Biotech
Boehringer blood thinner lawsuits due to start in August
Yahoo/Reuters
Wednesday, February 19, 2014 - 8:39am
tags:
Boehringer Ingelheim, bloodthinners, Pradaxa
Ranbaxy and Teva settle with NY Attorney General over collusion
Yahoo/Reuters
Wednesday, February 19, 2014 - 8:38am
tags:
collusion, Ranbaxy, Teva Pharmaceuticals, New York
MannKind Corporation's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Seeking Alpha
Wednesday, February 19, 2014 - 8:37am
tags:
MannKind, earnings
Sun Pharma gains on U.S. FDA approval of bone drug
Yahoo/Reuters
Wednesday, February 19, 2014 - 8:36am
tags:
Sun Pharma, FDA, osteoporosis, Ibandronate Sodium, Roche
Chelsea Therapeutics Wins FDA Approval For Northera
TheStreet.com
Tuesday, February 18, 2014 - 5:42pm
tags:
FDA, Northera, Chelsea Therapeutics, neurogenic orthostatic hypotension
J&J Says It Prevails in Suit Over Vaginal-Mesh
Bloomberg
Tuesday, February 18, 2014 - 3:41pm
tags:
JNJ, vaginal mesh
Forest Labs buyout may boost other drug stocks
USA Today
Tuesday, February 18, 2014 - 3:40pm
tags:
Forest Labs, M&A, Actavis
Neuralstem Phase 1 Data Gives Hope In ALS
Seeking Alpha
Tuesday, February 18, 2014 - 3:38pm
tags:
Neuralstem, amyotrophic lateral sclerosis, ALS, NSI-566
Dendreon: The Time Is Now
Seeking Alpha
Tuesday, February 18, 2014 - 11:33am
tags:
Dendreon, JNJ, Provenge, Medivation
Billionaire Teva Chairman May Retire by Year’s End
Bloomberg
Tuesday, February 18, 2014 - 10:36am
tags:
Teva Pharmaceuticals, Phillip Frost

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.